Beryl Drugs standalone net profit declines 30.19% in the June 2024 quarter

Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 as against Rs 0.53 crore during the previous quarter ended June 2023. Sales declined 22.93% to Rs 6.25 crore in the quarter ended June 2024 as against Rs 8.11 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	6.25	8.11	-23
OPM %	15.84	13.93	-
PBDT	0.78	1.01	-23
PBT	0.50	0.73	-32
NP	0.37	0.53	-30